Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15070 | 664 | 28.6 | 65% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2357 | 3920 | DUOCARMYCINS//PYRROLOBENZODIAZEPINE//PYRROLE IMIDAZOLE POLYAMIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PYRROLOBENZODIAZEPINE | Author keyword | 73 | 88% | 5% | 35 |
2 | PYRROLOBENZODIAZEPINES | Author keyword | 55 | 87% | 4% | 27 |
3 | PYRROLO2 1 C1 4BENZODIAZEPINES | Author keyword | 45 | 94% | 2% | 16 |
4 | CANC UK GENE TARGETED DRUG DESIGN GRP | Address | 38 | 89% | 3% | 17 |
5 | GENE TARGETED DRUG DESIGN GRP | Address | 26 | 80% | 2% | 16 |
6 | SPIROGEN LTD | Address | 21 | 90% | 1% | 9 |
7 | SJG 136 | Author keyword | 18 | 89% | 1% | 8 |
8 | GENE TARGETING DRUG DESIGN GRP | Address | 12 | 86% | 1% | 6 |
9 | PYRROLO2 1 C1 4BENZODIAZEPINE | Author keyword | 11 | 100% | 1% | 6 |
10 | CRC GENE TARGETED DRUG DESIGN GRP | Address | 8 | 100% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PYRROLOBENZODIAZEPINE | 73 | 88% | 5% | 35 | Search PYRROLOBENZODIAZEPINE | Search PYRROLOBENZODIAZEPINE |
2 | PYRROLOBENZODIAZEPINES | 55 | 87% | 4% | 27 | Search PYRROLOBENZODIAZEPINES | Search PYRROLOBENZODIAZEPINES |
3 | PYRROLO2 1 C1 4BENZODIAZEPINES | 45 | 94% | 2% | 16 | Search PYRROLO2+1+C1+4BENZODIAZEPINES | Search PYRROLO2+1+C1+4BENZODIAZEPINES |
4 | SJG 136 | 18 | 89% | 1% | 8 | Search SJG+136 | Search SJG+136 |
5 | PYRROLO2 1 C1 4BENZODIAZEPINE | 11 | 100% | 1% | 6 | Search PYRROLO2+1+C1+4BENZODIAZEPINE | Search PYRROLO2+1+C1+4BENZODIAZEPINE |
6 | PBDS | 8 | 100% | 1% | 5 | Search PBDS | Search PBDS |
7 | DNA BINDING ABILITY | 8 | 62% | 1% | 8 | Search DNA+BINDING+ABILITY | Search DNA+BINDING+ABILITY |
8 | DNA BINDING AFFINITY | 6 | 35% | 2% | 15 | Search DNA+BINDING+AFFINITY | Search DNA+BINDING+AFFINITY |
9 | ANTHRAMYCIN | 6 | 58% | 1% | 7 | Search ANTHRAMYCIN | Search ANTHRAMYCIN |
10 | DC 81 | 6 | 100% | 1% | 4 | Search DC+81 | Search DC+81 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTHRAMYCIN | 112 | 78% | 11% | 74 |
2 | TOMAYMYCIN | 93 | 91% | 6% | 39 |
3 | PYRROLO1 4BENZODIAZEPINE ANTITUMOR ANTIBIOTICS | 62 | 80% | 6% | 39 |
4 | SIBIROMYCIN | 49 | 94% | 3% | 17 |
5 | PYRROLOBENZODIAZEPINE DIMERS | 47 | 88% | 3% | 22 |
6 | SPECTRUM ANTITUMOR ACTIVITY | 42 | 83% | 4% | 24 |
7 | PYRROLO2 1 C1 4BENZODIAZEPINES | 39 | 74% | 4% | 29 |
8 | SJG 136 NSC 694501 | 31 | 82% | 3% | 18 |
9 | DC 81 | 27 | 65% | 4% | 26 |
10 | PYRROLO2 1 C1 4BENZODIAZEPINE | 22 | 81% | 2% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) | 2011 | 35 | 191 | 87% |
Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines | 2012 | 17 | 130 | 85% |
Pyrrolo[2,1-c][1,4]benzodiazepine as a Scaffold for the Design and Synthesis of Anti-Tumour Drugs | 2009 | 35 | 125 | 67% |
The development of pyrrolobenzodiazepines as antitumour agents | 2011 | 18 | 59 | 73% |
SYNTHESIS OF DNA-INTERACTIVE PYRROLO[2,1-C][1,4]BENZODIAZEPINES | 1994 | 219 | 102 | 77% |
Search for New and Novel Chemotherapeutics for the Treatment of Human Malignancies | 2010 | 14 | 215 | 39% |
Recent advances in the solid-phase combinatorial synthetic strategies for the benzodiazepine based privileged structures | 2006 | 42 | 69 | 30% |
The newer synthetic strategies for DNA binding pyrrolobenzodiazepine antibiotics | 1998 | 7 | 35 | 91% |
Synthetic Strategies Applicable in the Synthesis of Privileged Scaffold: 1,4-Benzodiazepine | 2014 | 3 | 77 | 19% |
Apoptosis-inducing agents: a patent review (2010-2013) | 2014 | 4 | 13 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC UK GENE TARGETED DRUG DESIGN GRP | 38 | 89% | 2.6% | 17 |
2 | GENE TARGETED DRUG DESIGN GRP | 26 | 80% | 2.4% | 16 |
3 | SPIROGEN LTD | 21 | 90% | 1.4% | 9 |
4 | GENE TARGETING DRUG DESIGN GRP | 12 | 86% | 0.9% | 6 |
5 | CRC GENE TARGETED DRUG DESIGN GRP | 8 | 100% | 0.8% | 5 |
6 | CR UK DRUG DNA INTERACT GRP | 5 | 60% | 0.9% | 6 |
7 | YORKSHIRE CANC DRUG DESIGN | 5 | 43% | 1.4% | 9 |
8 | QMB INNOVAT | 4 | 75% | 0.5% | 3 |
9 | EA IMT 6306 | 3 | 100% | 0.5% | 3 |
10 | UATRS ANGLE ALLAL FASSI FAR | 3 | 100% | 0.5% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184979 | 1 RUE VAUBENARD//UER SCI PHARMACEUT//TRIPENTONE |
2 | 0.0000111452 | DUOCARMYCINS//CC 1065//DUOCARMYCIN |
3 | 0.0000090640 | 1 5 BENZODIAZEPINES//1 5 BENZODIAZEPINE//O PHENYLENEDIAMINES |
4 | 0.0000084354 | PYRROLE IMIDAZOLE POLYAMIDE//DISTAMYCIN//MINOR GROOVE BINDERS |
5 | 0.0000074969 | DRUG DESIGN SYNTH//GUANINE DEAMINASE//GUANASE |
6 | 0.0000067503 | NITRILIMINE CYCLOADDITION//3A 7A DIHYDROINDAZOLES//STUDIO RELAZ STRUTT REATTIV CHIM |
7 | 0.0000059038 | 1 2 3 4 TETRAHYDROPYRAZINO1 2 AINDOLES//BENZOFUROPYRIDINE//IODOLACTONISATION |
8 | 0.0000053815 | SHARPLESS CONDITIONS//FLUOROORGAN//3H PYRIMIDIN 4 ONE |
9 | 0.0000045029 | ORGAN SYNTH GRP//4 HYDROXY 2 OXO 1 2 DIHYDROQUINOLINE 3 CARBOXAMIDES//4 HYDROXY 2 OXO 1 2 DIHYDROQUINOLINE 3 CARBOXYLIC ACIDS |
10 | 0.0000044234 | COMMUNESIN//PEROPHORAMIDINE//FLUSTRA FOLIACEA |